J B Chemicals Pharmaceuticals Ltd
JBCHEPHARM
Pharmaceuticals
₹ 1,706
Price
₹ 26,719
Market Cap
Large Cap
39.00
P/E Ratio
📊 Score Snapshot
20.0 / 25
Performance
24.26 / 25
Valuation
4.33 / 20
Growth
7.0 / 30
Profitability
55.6 / 100
Risky
🏢 Company Overview
⏳ Loading company overview...
🤖 CARL Insights
⏳ Loading CARL insights...
📈 Net Profit (Yearly)
📊 Sales (Yearly)
📉 Quarterly Sales Trend
📉 Quarterly Net Profit
📈 Yearly Ratios
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|
| Adj Cash EBITDA | 1,050 | 912.13 | 670.94 | 242.60 | 516.94 | 411.87 | 278.53 | 161.91 |
| Adj Cash EBITDA Margin | 27.15 | 26.73 | 21.59 | 11.38 | 26.21 | 23.36 | 16.84 | 11.95 |
| Adj Cash EBITDA To EBITDA | 1.01 | 0.99 | 0.96 | 0.45 | 0.85 | 1.02 | 0.85 | 0.78 |
| Adj Cash EPS | 44.10 | 35.97 | 24.74 | 7.24 | 25.94 | 19.10 | 9.62 | 7.39 |
| Adj Cash PAT | 687.12 | 558.69 | 382.95 | 112.76 | 401.96 | 295.09 | 155.11 | 124.21 |
| Adj Cash PAT To PAT | 1.01 | 0.99 | 0.93 | 0.27 | 0.81 | 1.04 | 0.75 | 0.73 |
| Adj Cash PE | 36.21 | 48.78 | 40.15 | 143.87 | 27.33 | 12.27 | 19.83 | 28.17 |
| Adj EPS | 43.65 | 36.36 | 26.68 | 26.80 | 32.02 | 18.45 | 12.80 | 10.21 |
| Adj EV To Cash EBITDA | 22.57 | 29.12 | 23.16 | 49.59 | 17.42 | 7.42 | 8.42 | 13.16 |
| Adj EV To EBITDA | 22.73 | 28.93 | 22.17 | 22.09 | 14.74 | 7.60 | 7.12 | 10.20 |
| Adj Number Of Shares | 15.58 | 15.53 | 15.48 | 15.44 | 15.46 | 15.45 | 16.02 | 16.67 |
| Adj PE | 36.59 | 48.25 | 37.21 | 31.24 | 21.59 | 12.72 | 14.59 | 18.59 |
| Adj Peg | 1.82 | 1.33 | - | - | 0.29 | 0.29 | 0.58 | - |
| Bvps | 220.41 | 188.28 | 160.21 | 138.47 | 117.27 | 93.01 | 92.57 | 86.68 |
| Cash Conversion Cycle | 109.00 | 117.00 | 127.00 | 164.00 | 153.00 | 133.00 | 146.00 | 148.00 |
| Cash ROCE | 20.94 | 14.03 | -9.40 | -28.01 | 23.01 | 17.92 | 9.92 | 6.29 |
| Cash Roic | 19.33 | 12.67 | -8.43 | -27.47 | 24.26 | 18.84 | 10.24 | 7.64 |
| Cash Revenue | 3,868 | 3,412 | 3,107 | 2,131 | 1,972 | 1,763 | 1,654 | 1,355 |
| Cash Revenue To Revenue | 0.99 | 0.98 | 0.99 | 0.88 | 0.97 | 0.99 | 1.01 | 0.96 |
| Dio | 147.00 | 155.00 | 134.00 | 178.00 | 181.00 | 159.00 | 149.00 | 145.00 |
| Dpo | 114.00 | 110.00 | 75.00 | 97.00 | 97.00 | 97.00 | 72.00 | 75.00 |
| Dso | 76.00 | 72.00 | 67.00 | 84.00 | 70.00 | 71.00 | 68.00 | 78.00 |
| Dividend Yield | 1.01 | 0.71 | 0.91 | 1.05 | 1.30 | 2.43 | 1.44 | 0.64 |
| EV | 23,709 | 26,561 | 15,542 | 12,030 | 9,005 | 3,055 | 2,347 | 2,131 |
| EV To EBITDA | 23.33 | 29.44 | 22.30 | 23.73 | 16.42 | 7.93 | 7.53 | 13.00 |
| EV To Fcff | 33.89 | 61.74 | - | - | 26.10 | 12.31 | 17.78 | 22.05 |
| Fcfe | 395.12 | 244.69 | 255.95 | -513.24 | 470.96 | 296.09 | 169.11 | 157.21 |
| Fcfe Margin | 10.22 | 7.17 | 8.24 | -24.08 | 23.88 | 16.79 | 10.22 | 11.60 |
| Fcfe To Adj PAT | 0.58 | 0.43 | 0.62 | -1.24 | 0.95 | 1.04 | 0.82 | 0.92 |
| Fcff | 699.67 | 430.17 | -250.82 | -568.73 | 345.03 | 248.17 | 132.00 | 96.64 |
| Fcff Margin | 18.09 | 12.61 | -8.07 | -26.69 | 17.50 | 14.08 | 7.98 | 7.13 |
| Fcff To NOPAT | 1.09 | 0.77 | -0.58 | -1.58 | 0.93 | 1.02 | 0.78 | 0.84 |
| Market Cap | 24,155 | 26,667 | 15,255 | 12,051 | 9,673 | 3,462 | 2,818 | 2,569 |
| PB | 7.03 | 9.12 | 6.15 | 5.64 | 5.34 | 2.41 | 1.90 | 1.78 |
| PE | 36.59 | 48.22 | 37.21 | 31.31 | 21.59 | 12.73 | 14.60 | 18.61 |
| Peg | 1.93 | 1.40 | 5.98 | - | 0.33 | 0.28 | 0.32 | - |
| PS | 6.17 | 7.65 | 4.84 | 4.97 | 4.73 | 1.95 | 1.71 | 1.82 |
| ROCE | 19.20 | 18.06 | 16.53 | 17.79 | 24.51 | 17.59 | 12.40 | 7.54 |
| ROE | 21.39 | 20.90 | 17.88 | 21.00 | 30.52 | 19.53 | 14.08 | 12.18 |
| Roic | 17.70 | 16.44 | 14.43 | 17.35 | 26.01 | 18.46 | 13.11 | 9.07 |
| Share Price | 1,550 | 1,717 | 985.45 | 780.50 | 625.68 | 224.10 | 175.88 | 154.13 |
📊 Quarterly Results
| Metric | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,085 | 1,094 | 949.00 | 963.00 | 1,001 | 1,004 | 862.00 | 845.00 | 882.00 | 896.00 | 762.00 | 793.00 | 809.00 | 785.00 |
| Interest | 1.00 | 1.00 | 1.00 | 3.00 | 2.00 | 6.00 | 9.00 | 12.00 | 10.00 | 12.00 | 14.00 | 8.00 | 8.00 | 6.00 |
| Expenses - | 775.00 | 793.00 | 723.00 | 709.00 | 730.00 | 724.00 | 664.00 | 621.00 | 638.00 | 664.00 | 599.00 | 618.00 | 625.00 | 612.00 |
| Other Income - | 15.34 | 14.55 | 14.48 | 8.00 | 9.95 | 5.89 | 16.63 | 7.35 | 7.66 | 5.63 | 4.58 | 3.13 | 1.34 | 0.89 |
| Depreciation | 44.00 | 43.00 | 46.00 | 42.00 | 42.00 | 41.00 | 41.00 | 34.00 | 32.00 | 31.00 | 32.00 | 28.00 | 28.00 | 26.00 |
| Profit Before Tax | 279.00 | 272.00 | 193.00 | 218.00 | 237.00 | 240.00 | 165.00 | 184.00 | 209.00 | 194.00 | 122.00 | 141.00 | 150.00 | 142.00 |
| Tax % | 25.45 | 25.74 | 24.35 | 25.69 | 26.16 | 26.25 | 23.64 | 27.17 | 27.75 | 26.80 | 27.87 | 24.82 | 26.00 | 26.06 |
| Net Profit - | 208.00 | 202.00 | 146.00 | 162.00 | 175.00 | 177.00 | 126.00 | 134.00 | 151.00 | 142.00 | 88.00 | 106.00 | 111.00 | 105.00 |
| Profit Excl Exceptional | 208.00 | 202.00 | 146.00 | 162.00 | 175.00 | 177.00 | 126.00 | 134.00 | 151.00 | 142.00 | 88.00 | 106.00 | 111.00 | 105.00 |
| Profit For PE | 208.00 | 202.00 | 146.00 | 162.00 | 175.00 | 177.00 | 126.00 | 134.00 | 151.00 | 142.00 | 88.00 | 106.00 | 111.00 | 105.00 |
| Profit For EPS | 208.00 | 202.00 | 146.00 | 162.00 | 175.00 | 177.00 | 126.00 | 134.00 | 151.00 | 142.00 | 88.00 | 106.00 | 111.00 | 105.00 |
| EPS In Rs | 13.27 | 12.97 | 9.36 | 10.45 | 11.24 | 11.39 | 8.13 | 8.61 | 9.72 | 9.19 | 5.66 | 6.86 | 7.18 | 6.79 |
| PAT Margin % | 19.17 | 18.46 | 15.38 | 16.82 | 17.48 | 17.63 | 14.62 | 15.86 | 17.12 | 15.85 | 11.55 | 13.37 | 13.72 | 13.38 |
| PBT Margin | 25.71 | 24.86 | 20.34 | 22.64 | 23.68 | 23.90 | 19.14 | 21.78 | 23.70 | 21.65 | 16.01 | 17.78 | 18.54 | 18.09 |
| Tax | 71.00 | 70.00 | 47.00 | 56.00 | 62.00 | 63.00 | 39.00 | 50.00 | 58.00 | 52.00 | 34.00 | 35.00 | 39.00 | 37.00 |
| Yoy Profit Growth % | 19.00 | 14.00 | 15.00 | 22.00 | 16.00 | 24.00 | 44.00 | 26.00 | 36.00 | 36.00 | 3.00 | 26.00 | 14.00 | -12.00 |
| Adj Ebit | 281.34 | 272.55 | 194.48 | 220.00 | 238.95 | 244.89 | 173.63 | 197.35 | 219.66 | 206.63 | 135.58 | 150.13 | 157.34 | 147.89 |
| Adj EBITDA | 325.34 | 315.55 | 240.48 | 262.00 | 280.95 | 285.89 | 214.63 | 231.35 | 251.66 | 237.63 | 167.58 | 178.13 | 185.34 | 173.89 |
| Adj EBITDA Margin | 29.99 | 28.84 | 25.34 | 27.21 | 28.07 | 28.48 | 24.90 | 27.38 | 28.53 | 26.52 | 21.99 | 22.46 | 22.91 | 22.15 |
| Adj Ebit Margin | 25.93 | 24.91 | 20.49 | 22.85 | 23.87 | 24.39 | 20.14 | 23.36 | 24.90 | 23.06 | 17.79 | 18.93 | 19.45 | 18.84 |
| Adj PAT | 208.00 | 202.00 | 146.00 | 162.00 | 175.00 | 177.00 | 126.00 | 134.00 | 151.00 | 142.00 | 88.00 | 106.00 | 111.00 | 105.00 |
| Adj PAT Margin | 19.17 | 18.46 | 15.38 | 16.82 | 17.48 | 17.63 | 14.62 | 15.86 | 17.12 | 15.85 | 11.55 | 13.37 | 13.72 | 13.38 |
| Ebit | 281.34 | 272.55 | 194.48 | 220.00 | 238.95 | 244.89 | 173.63 | 197.35 | 219.66 | 206.63 | 135.58 | 150.13 | 157.34 | 147.89 |
| EBITDA | 325.34 | 315.55 | 240.48 | 262.00 | 280.95 | 285.89 | 214.63 | 231.35 | 251.66 | 237.63 | 167.58 | 178.13 | 185.34 | 173.89 |
| EBITDA Margin | 29.99 | 28.84 | 25.34 | 27.21 | 28.07 | 28.48 | 24.90 | 27.38 | 28.53 | 26.52 | 21.99 | 22.46 | 22.91 | 22.15 |
| Ebit Margin | 25.93 | 24.91 | 20.49 | 22.85 | 23.87 | 24.39 | 20.14 | 23.36 | 24.90 | 23.06 | 17.79 | 18.93 | 19.45 | 18.84 |
| NOPAT | 198.30 | 191.59 | 136.17 | 157.54 | 169.09 | 176.26 | 119.89 | 138.38 | 153.17 | 147.13 | 94.49 | 110.51 | 115.44 | 108.69 |
| NOPAT Margin | 18.28 | 17.51 | 14.35 | 16.36 | 16.89 | 17.56 | 13.91 | 16.38 | 17.37 | 16.42 | 12.40 | 13.94 | 14.27 | 13.85 |
| Operating Profit | 266.00 | 258.00 | 180.00 | 212.00 | 229.00 | 239.00 | 157.00 | 190.00 | 212.00 | 201.00 | 131.00 | 147.00 | 156.00 | 147.00 |
| Operating Profit Margin | 24.52 | 23.58 | 18.97 | 22.01 | 22.88 | 23.80 | 18.21 | 22.49 | 24.04 | 22.43 | 17.19 | 18.54 | 19.28 | 18.73 |
💰 Profit & Loss
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,918 | 3,484 | 3,149 | 2,424 | 2,043 | 1,775 | 1,643 | 1,408 | 1,344 | 1,210 | 1,144 | 1,022 |
| Interest | 12.00 | 44.00 | 36.00 | 5.00 | 7.00 | 3.00 | 5.00 | 3.00 | 5.00 | 11.00 | 7.00 | 6.00 |
| Expenses - | 2,886 | 2,587 | 2,454 | 1,881 | 1,482 | 1,397 | 1,337 | 1,191 | 1,112 | 1,004 | 964.00 | 874.00 |
| Other Income - | 11.28 | 21.13 | 5.94 | 1.60 | 49.94 | 23.87 | 23.53 | -8.09 | 3.96 | 24.35 | 1.67 | 19.48 |
| Exceptional Items | 27.04 | 15.90 | 4.00 | 37.63 | 62.44 | 16.80 | 17.91 | 44.95 | 46.20 | 33.68 | 9.09 | -46.28 |
| Depreciation | 171.00 | 138.00 | 114.00 | 73.00 | 69.00 | 66.00 | 56.00 | 57.00 | 47.00 | 41.00 | 39.00 | 28.00 |
| Profit Before Tax | 887.00 | 752.00 | 555.00 | 505.00 | 597.00 | 349.00 | 287.00 | 194.00 | 230.00 | 212.00 | 146.00 | 87.00 |
| Tax % | 25.59 | 26.46 | 26.13 | 23.56 | 24.79 | 22.06 | 32.40 | 28.35 | 20.00 | 23.11 | 31.51 | 28.74 |
| Net Profit - | 660.00 | 553.00 | 410.00 | 386.00 | 449.00 | 272.00 | 194.00 | 139.00 | 184.00 | 163.00 | 100.00 | 62.00 |
| Minority Share | - | - | - | -1.00 | -1.00 | - | - | - | - | - | - | - |
| Exceptional Items At | 20.00 | 12.00 | 3.00 | 28.00 | 47.00 | 13.00 | 12.00 | 33.00 | 34.00 | 26.00 | 6.00 | -27.00 |
| Profit Excl Exceptional | 640.00 | 541.00 | 407.00 | 358.00 | 402.00 | 260.00 | 182.00 | 106.00 | 151.00 | 137.00 | 94.00 | 89.00 |
| Profit For PE | 640.00 | 541.00 | 407.00 | 357.00 | 401.00 | 259.00 | 181.00 | 106.00 | 150.00 | 137.00 | 94.00 | 89.00 |
| Profit For EPS | 660.00 | 553.00 | 410.00 | 385.00 | 448.00 | 272.00 | 193.00 | 138.00 | 184.00 | 163.00 | 100.00 | 62.00 |
| EPS In Rs | 42.37 | 35.61 | 26.48 | 24.93 | 28.98 | 17.60 | 12.05 | 8.28 | 10.85 | 9.58 | 5.92 | 3.63 |
| Dividend Payout % | 37.00 | 34.00 | 34.00 | 33.00 | 28.00 | 31.00 | 21.00 | 12.00 | 5.00 | 26.00 | 118.00 | 41.00 |
| PAT Margin % | 16.85 | 15.87 | 13.02 | 15.92 | 21.98 | 15.32 | 11.81 | 9.87 | 13.69 | 13.47 | 8.74 | 6.07 |
| PBT Margin | 22.64 | 21.58 | 17.62 | 20.83 | 29.22 | 19.66 | 17.47 | 13.78 | 17.11 | 17.52 | 12.76 | 8.51 |
| Tax | 227.00 | 199.00 | 145.00 | 119.00 | 148.00 | 77.00 | 93.00 | 55.00 | 46.00 | 49.00 | 46.00 | 25.00 |
| Adj Ebit | 872.28 | 780.13 | 586.94 | 471.60 | 541.94 | 335.87 | 273.53 | 151.91 | 188.96 | 189.35 | 142.67 | 139.48 |
| Adj EBITDA | 1,043 | 918.13 | 700.94 | 544.60 | 610.94 | 401.87 | 329.53 | 208.91 | 235.96 | 230.35 | 181.67 | 167.48 |
| Adj EBITDA Margin | 26.63 | 26.35 | 22.26 | 22.47 | 29.90 | 22.64 | 20.06 | 14.84 | 17.56 | 19.04 | 15.88 | 16.39 |
| Adj Ebit Margin | 22.26 | 22.39 | 18.64 | 19.46 | 26.53 | 18.92 | 16.65 | 10.79 | 14.06 | 15.65 | 12.47 | 13.65 |
| Adj PAT | 680.12 | 564.69 | 412.95 | 414.76 | 495.96 | 285.09 | 206.11 | 171.21 | 220.96 | 188.90 | 106.23 | 29.02 |
| Adj PAT Margin | 17.36 | 16.21 | 13.11 | 17.11 | 24.28 | 16.06 | 12.54 | 12.16 | 16.44 | 15.61 | 9.29 | 2.84 |
| Ebit | 845.24 | 764.23 | 582.94 | 433.97 | 479.50 | 319.07 | 255.62 | 106.96 | 142.76 | 155.67 | 133.58 | 185.76 |
| EBITDA | 1,016 | 902.23 | 696.94 | 506.97 | 548.50 | 385.07 | 311.62 | 163.96 | 189.76 | 196.67 | 172.58 | 213.76 |
| EBITDA Margin | 25.94 | 25.90 | 22.13 | 20.91 | 26.85 | 21.69 | 18.97 | 11.64 | 14.12 | 16.25 | 15.09 | 20.92 |
| Ebit Margin | 21.57 | 21.94 | 18.51 | 17.90 | 23.47 | 17.98 | 15.56 | 7.60 | 10.62 | 12.87 | 11.68 | 18.18 |
| NOPAT | 640.67 | 558.17 | 429.18 | 359.27 | 370.03 | 243.17 | 169.00 | 114.64 | 148.00 | 126.87 | 96.57 | 85.51 |
| NOPAT Margin | 16.35 | 16.02 | 13.63 | 14.82 | 18.11 | 13.70 | 10.29 | 8.14 | 11.01 | 10.49 | 8.44 | 8.37 |
| Operating Profit | 861.00 | 759.00 | 581.00 | 470.00 | 492.00 | 312.00 | 250.00 | 160.00 | 185.00 | 165.00 | 141.00 | 120.00 |
| Operating Profit Margin | 21.98 | 21.79 | 18.45 | 19.39 | 24.08 | 17.58 | 15.22 | 11.36 | 13.76 | 13.64 | 12.33 | 11.74 |
🏦 Balance Sheet
| Metric | Sep 2025 | Mar 2025 | Sep 2024 | Mar 2024 | Sep 2023 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated Depreciation | - | 996.00 | - | 831.00 | - | 707.00 | 599.00 | 549.00 | 526.00 | 464.00 |
| Advance From Customers | - | 10.00 | - | 13.00 | - | 12.00 | 4.00 | 4.00 | 21.00 | 13.00 |
| Average Capital Employed | 3,564 | 3,381 | 3,230 | 3,176 | - | 2,623 | 2,026 | 1,663 | 1,488 | 1,492 |
| Average Invested Capital | 2,988 | 3,620 | 2,800 | 3,395 | - | 2,974 | 2,070 | 1,422 | 1,318 | 1,289 |
| Average Total Assets | 4,370 | 4,126 | 3,914 | 3,768 | - | 3,074 | 2,416 | 2,022 | 1,803 | 1,778 |
| Average Total Equity | 3,510 | 3,179 | 2,965 | 2,702 | - | 2,309 | 1,976 | 1,625 | 1,460 | 1,464 |
| Cwip | 32.00 | 63.00 | 42.00 | 76.00 | 72.00 | 55.00 | 19.00 | 26.00 | 16.00 | 15.00 |
| Capital Employed | 3,824 | 3,461 | 3,305 | 3,301 | 3,154 | 3,052 | 2,194 | 1,858 | 1,468 | 1,509 |
| Cash Equivalents | 104.00 | 129.00 | 97.00 | 96.00 | 93.00 | 79.00 | 59.00 | 31.00 | 31.00 | 37.00 |
| Fixed Assets | 1,977 | 1,968 | 2,016 | 2,004 | 1,917 | 1,901 | 1,277 | 634.00 | 651.00 | 621.00 |
| Gross Block | - | 2,965 | - | 2,835 | - | 2,608 | 1,876 | 1,183 | 1,177 | 1,085 |
| Inventory | 577.00 | 529.00 | 544.00 | 503.00 | 425.00 | 430.00 | 410.00 | 347.00 | 275.00 | 244.00 |
| Invested Capital | 3,122 | 3,763 | 2,853 | 3,477 | 2,746 | 3,313 | 2,636 | 1,505 | 1,340 | 1,295 |
| Investments | 519.00 | 345.00 | 345.00 | 388.00 | 315.00 | 206.00 | 13.00 | 678.00 | 403.00 | 457.00 |
| Lease Liabilities | 11.91 | 14.08 | 11.00 | 20.52 | 10.00 | 24.21 | 28.25 | 12.34 | - | - |
| Loans N Advances | 79.00 | 38.00 | 11.00 | 28.00 | - | 31.00 | 44.00 | 33.00 | 38.00 | 30.00 |
| Long Term Borrowings | - | - | - | 23.64 | 279.00 | 383.22 | - | - | - | - |
| Net Debt | -604.00 | -446.00 | -349.00 | -106.00 | 29.00 | 287.00 | -17.00 | -664.00 | -405.00 | -468.00 |
| Net Working Capital | 1,113 | 1,732 | 795.00 | 1,397 | 757.00 | 1,357 | 1,340 | 845.00 | 673.00 | 659.00 |
| Non Controlling Interest | - | - | - | - | - | - | 4.00 | 4.00 | 2.00 | 3.00 |
| Other Asset Items | 486.00 | 377.00 | 158.00 | 206.00 | 261.00 | 269.00 | 224.00 | 93.00 | 54.00 | 81.00 |
| Other Borrowings | - | 0.01 | - | -0.01 | - | - | -0.01 | - | - | - |
| Other Liability Items | 478.00 | 383.00 | 382.00 | 318.00 | 323.00 | 244.00 | 179.00 | 182.00 | 157.00 | 153.00 |
| Reserves | 3,790 | 3,418 | 3,197 | 2,908 | 2,701 | 2,465 | 2,119 | 1,794 | 1,420 | 1,464 |
| Share Capital | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 15.00 | 15.00 | 15.00 | 15.00 | 16.00 |
| Short Term Borrowings | 7.32 | 13.80 | 82.00 | 333.50 | 148.00 | 165.02 | 26.32 | 32.64 | 29.49 | 25.80 |
| Short Term Loans And Advances | - | - | - | 1.00 | 1.00 | 1.00 | 1.00 | - | - | 1.00 |
| Total Assets | 4,712 | 4,265 | 4,029 | 3,988 | 3,799 | 3,547 | 2,601 | 2,231 | 1,814 | 1,792 |
| Total Borrowings | 19.00 | 28.00 | 93.00 | 378.00 | 437.00 | 572.00 | 55.00 | 45.00 | 29.00 | 26.00 |
| Total Equity | 3,806 | 3,434 | 3,213 | 2,924 | 2,717 | 2,480 | 2,138 | 1,813 | 1,437 | 1,483 |
| Total Equity And Liabilities | 4,712 | 4,265 | 4,029 | 3,988 | 3,799 | 3,547 | 2,601 | 2,231 | 1,814 | 1,792 |
| Total Liabilities | 906.00 | 831.00 | 816.00 | 1,064 | 1,082 | 1,067 | 463.00 | 418.00 | 377.00 | 309.00 |
| Trade Payables | 410.00 | 411.00 | 342.00 | 356.00 | 322.00 | 239.00 | 224.00 | 187.00 | 168.00 | 117.00 |
| Trade Receivables | 938.00 | 1,630 | 817.00 | 1,374 | 715.00 | 1,152 | 1,112 | 778.00 | 690.00 | 616.00 |
💵 Cash Flows
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|
| Cash From Financing Activity | -580.00 | -385.00 | 357.00 | -138.00 | -87.00 | -306.00 | -156.00 | -60.00 |
| Cash From Investing Activity | -296.00 | -404.00 | -962.00 | 2.00 | -231.00 | 24.00 | -28.00 | -21.00 |
| Cash From Operating Activity | 902.00 | 801.00 | 626.00 | 170.00 | 315.00 | 276.00 | 194.00 | 123.00 |
| Cash Paid For Investment In Subsidaries And Associates | - | - | - | - | - | - | - | - |
| Cash Paid For Purchase Of Fixed Assets | -120.00 | -261.00 | -765.00 | -707.00 | -48.00 | -73.00 | -49.00 | -36.00 |
| Cash Paid For Purchase Of Investments | -980.00 | -869.00 | -743.00 | -508.00 | -541.00 | -383.00 | -425.00 | -420.00 |
| Cash Paid For Repayment Of Borrowings | -344.00 | -192.00 | -87.00 | - | - | - | - | - |
| Cash Received From Borrowings | - | - | 610.00 | - | - | 6.00 | - | 4.00 |
| Cash Received From Issue Of Shares | 24.00 | 20.00 | 8.00 | - | - | - | - | - |
| Cash Received From Sale Of Fixed Assets | 1.00 | 1.00 | 1.00 | 8.00 | 48.00 | 2.00 | 7.00 | 8.00 |
| Cash Received From Sale Of Investments | 1,055 | 719.00 | 557.00 | 1,209 | 317.00 | 474.00 | 436.00 | 423.00 |
| Change In Inventory | -26.00 | -72.00 | -21.00 | -63.00 | -70.00 | -31.00 | -30.00 | -14.00 |
| Change In Other Working Capital Items | - | - | - | - | - | - | -4.00 | - |
| Change In Payables | 83.00 | 138.00 | 32.00 | 53.00 | 46.00 | 52.00 | -29.00 | 19.00 |
| Change In Receivables | -50.00 | -72.00 | -42.00 | -293.00 | -71.00 | -12.00 | 11.00 | -53.00 |
| Change In Working Capital | 7.00 | -6.00 | -30.00 | -302.00 | -94.00 | 10.00 | -51.00 | -47.00 |
| Direct Taxes Paid | -201.00 | -132.00 | -95.00 | -135.00 | -142.00 | -91.00 | -65.00 | -41.00 |
| Dividends Paid | -237.00 | -157.00 | -128.00 | -128.00 | -73.00 | -141.00 | -21.00 | -10.00 |
| Dividends Received | - | - | - | - | - | 1.00 | 1.00 | - |
| Interest Paid | -10.00 | -44.00 | -32.00 | -2.00 | -6.00 | -2.00 | -4.00 | -3.00 |
| Interest Received | 5.00 | 4.00 | 2.00 | 1.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Net Cash Flow | 27.00 | 11.00 | 20.00 | 34.00 | -3.00 | -6.00 | 11.00 | 43.00 |
| Other Cash Financing Items Paid | -13.00 | -13.00 | -16.00 | -8.00 | -8.00 | -170.00 | -131.00 | -50.00 |
| Other Cash Investing Items Paid | -257.00 | 2.00 | -13.00 | - | -9.00 | -1.00 | 1.00 | 3.00 |
| Profit From Operations | 1,096 | 939.00 | 751.00 | 607.00 | 551.00 | 357.00 | 311.00 | 211.00 |
🧾 Shareholding Pattern
| Nse Code | Date | Promoters | Fii | Dii | Public | Others |
|---|---|---|---|---|---|---|
| Jbchepharm | 2025-09-30 | - | 15.31 | 22.83 | 14.31 | 0.00 |
| Jbchepharm | 2025-06-30 | - | 17.77 | 19.62 | 14.87 | 0.00 |
| Jbchepharm | 2025-03-31 | - | 18.30 | 18.71 | 15.13 | 0.00 |
| Jbchepharm | 2024-12-31 | - | 14.64 | 16.40 | 15.29 | 0.00 |
💬
Stock Chat